A carregar...
CAR Therapy for CLL: What are the Challenges?
Numerous targeted therapies are being developed for patients with CLL. CAR-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy and recent results from four different trials highlight the dramatic potential of this therapy for patients with relapsed CLL. Sinc...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3615434/ https://ncbi.nlm.nih.gov/pubmed/23561477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2012.12.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|